Kush Parmar's most recent trade in Entrada Therapeutics Inc was a trade of 55,735 Common Stock done at an average price of $6.9 . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.91 per share. | 27 Jun 2025 | 55,735 | 3,220,287 | - | 6.9 | 385,129 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.91 per share. | 27 Jun 2025 | 19,265 | 1,113,092 | - | 6.9 | 133,121 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.12 per share. | 27 Jun 2025 | 18,578 | 3,183,131 | - | 7.1 | 132,324 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.81 per share. | 27 Jun 2025 | 18,578 | 3,201,709 | - | 6.8 | 126,566 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.12 per share. | 27 Jun 2025 | 6,422 | 1,100,248 | - | 7.1 | 45,741 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.81 per share. | 27 Jun 2025 | 6,422 | 1,106,670 | - | 6.8 | 43,751 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Rallybio Corp | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| Rallybio Corp | M. Kush Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 27,118 | 27,118 | - | - | Option (Right to Buy) | |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Rallybio Corp | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 8.20 per share. | 07 Mar 2023 | 100,000 | 2,378,969 | - | 8.2 | 820,000 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,344 | 10,344 | - | - | Option (Right to Buy) | |
| Q32 Bio Inc. | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,911 | 16,911 | - | - | Stock Option (right to buy) | |
| Rallybio Corp | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 03 Jun 2022 | 99,671 | 2,478,969 | - | 12.5 | 1,245,888 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 03 Jun 2022 | 50,329 | 1,251,755 | - | 12.5 | 629,113 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Rallybio Corp | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 23 May 2022 | 66,447 | 2,578,640 | - | 13 | 863,811 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 23 May 2022 | 33,553 | 1,302,084 | - | 13 | 436,189 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 08 Feb 2022 | 139,539 | 2,645,087 | - | 13.1 | 1,820,984 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 08 Feb 2022 | 70,461 | 1,335,637 | - | 13.0 | 919,516 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,772 | 5,772 | - | - | Option (Right to Buy) | |
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 16 Nov 2021 | 238,870 | 4,595,089 | - | 15.3 | 3,654,711 | Common Stock |
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 16 Nov 2021 | 91,836 | 1,766,634 | - | 15.3 | 1,405,091 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 2,371,739 | 3,021,510 | - | - | Common Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 2,371,739 | 0 | - | - | Series A Preferred Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 564,217 | 564,217 | - | - | Common Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 564,217 | 0 | - | - | Series A Preferred Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,616 | 649,771 | - | - | Common Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,616 | 0 | - | - | Series Seed Preferred Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,140 | 882,357 | - | - | Common Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,140 | 0 | - | - | Series B Preferred Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 254,512 | 3,276,022 | - | - | Common Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 254,512 | 0 | - | - | Series B Preferred Stock | ||
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 02 Nov 2021 | 250,000 | 1,132,357 | - | 20 | 5,000,000 | Common Stock |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 23,552 | 23,552 | - | - | Stock Option (Right to Buy) | |
| Rallybio Corp | Kush M. Parmar | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 8,742,654 | 0 | - | - | Series A-2 Preferred Units | |
| Rallybio Corp | Kush M. Parmar | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 7,192,795 | 0 | - | - | Series B Preferred Units | |
| Rallybio Corp | Kush M. Parmar | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 5,034,955 | 0 | - | - | Series B Preferred Units | |
| Rallybio Corp | Kush M. Parmar | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 2,784,626 | 2,784,626 | - | - | Common Stock | |
| Rallybio Corp | Kush M. Parmar | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 1,795,946 | 0 | - | - | Series A-1 Preferred Units | |
| Rallybio Corp | Kush M. Parmar | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2021 | 790,714 | 790,714 | - | - | Common Stock | |
| Rallybio Corp | Kush M. Parmar | Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 28 Jul 2021 | 615,384 | 1,406,098 | - | 13 | 7,999,992 | Common Stock |
| Rallybio Corp | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Q32 Bio Inc. | Kush M. Parmar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | 05 Feb 2021 | 45,000,000 | 0 | - | - | Series A-2 Preferred Stock | ||
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | 05 Feb 2021 | 19,230,768 | 0 | - | - | Series B Preferred Stock | ||
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | 05 Feb 2021 | 19,230,768 | 0 | - | - | Series B Preferred Stock | ||
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | 05 Feb 2021 | 3,308,822 | 3,308,822 | - | - | Common Stock | ||
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | 05 Feb 2021 | 1,414,026 | 1,414,026 | - | - | Common Stock | ||
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | 05 Feb 2021 | 1,414,026 | 4,722,848 | - | - | Common Stock | ||
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 05 Feb 2021 | 444,444 | 1,858,470 | - | 18 | 7,999,992 | Common Stock |
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 05 Feb 2021 | 111,111 | 4,833,959 | - | 18 | 1,999,998 | Common Stock |
| Vor Biopharma Inc | Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 16,900 | 16,900 | - | - | Stock Option (right to buy) | |
| Q32 Bio Inc. | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 22 Dec 2020 | 480,000 | 4,354,484 (9%) | 1% | 12.8 | 6,153,600 | Common Stock |
| Q32 Bio Inc. | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 22 Dec 2020 | 20,000 | 181,435 (0%) | 0% | 12.8 | 256,400 | Common Stock |
| Q32 Bio Inc. | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 11.88 per share. | 14 Dec 2020 | 328,862 | 4,834,484 (10%) | 0% | 11.9 | 3,906,881 | Common Stock |
| Q32 Bio Inc. | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 14 Dec 2020 | 151,138 | 5,163,346 (11%) | 0% | 13.1 | 1,973,998 | Common Stock |
| Q32 Bio Inc. | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 11.88 per share. | 14 Dec 2020 | 13,703 | 201,435 (0%) | 0% | 11.9 | 162,792 | Common Stock |
| Q32 Bio Inc. | Kush M. Parmar | Director | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 14 Dec 2020 | 6,297 | 215,138 (0%) | 0% | 13.1 | 82,244 | Common Stock |